20.500.12556/RUL-122088 Telemedicine in radiation oncology post-COVID-19 pandemic there is no turning back Purpose We aimed to assess patients’ and physicians’ perspectives on wider implementation of telemedicine in radiation oncology practice, disrupted by the novel coronavirus disease 2019 (COVID-19). Methods Quantitative questionnaires were prepared and distributed between May 27 and June 11, 2020. A 29-question survey targeting patients with cancer was distributed electronically via cancer support organizations. Cross-sectional data from a selected weekday at a radiation oncology department were also analyzed. In addition, a 25-question survey was distributed to 168 physicians employed by a comprehensive cancer center. Results In total, we have analyzed 468 patients’ and 101 physicians’ responses. Among responding patients, 310 were undergoing active treatment and 158 were in follow-up care. Both patients and physicians reported no experiences with video consultations during the COVID-19 pandemic, but 15% of patients stated that they missed telemedicine services that would include a video call. Overall, 30.6% of patients expressed interest in more frequent usage of telemedicine and 23.3% would start using it. Sixty-seven percent of radiation oncologists expressed interest in more frequent usage of telemedicine, and 14% would use it similarly as in the past. For patients treated with radiation therapy (RT), 59.9% and 63.4% of the responding patients acknowledged that video consultations would be an important addition to medical care during RT course or after the completion of RT, respectively. Comparably, 61.1% and 63.9% of radiation oncologists believed video consultations would be useful or extremely useful for patients undergoing RT or for patients in the follow-up setting, respectively. Conclusions The post–COVID-19 era represents a unique chance to improve and guarantee continuity of cancer care via telemedicine solutions, when appropriate. telemedicine radiotherapy oncology covid-19 telemedicina radioterapija onkologija covid-19 true false true Angleški jezik Slovenski jezik Neznano 2020-11-20 08:51:28 2020-11-20 08:51:32 2022-09-02 04:02:19 0000-00-00 00:00:00 2020 0 0 Str. 411-415 iss. 2 Vol. 108 2020 0000-00-00 PostprintKoncna Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 2021-09-02 615.82/.84 0360-3016 10.1016/j.ijrobp.2020.06.052 26998531 RAZ_Orazem_Miha_2020.pdf RAZ_Orazem_Miha_2020.pdf 1 FD747F212F7B21DC6B452554AEF49EC4 9fcda8e95695c0e9c0416111cc7a56173f644553204ba7c3ded70b70c4b358dd a616d23a-a1bb-11eb-a523-00155dcfd717 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=140643 https://www.sciencedirect.com/science/article/abs/pii/S0360301620313390?via%3Dihub 1 https://repozitorij.uni-lj.si/Dokument.php?lang=slv&id=139623 Medicinska fakulteta 0 0 0